AVP and type 2 diabetes mellitus: Recent work aimed at finding novel biomarkers of PD and T2D has resulted in the identification of copeptin, which is the C-terminal fragment of pre-provasopressin (Enhorning et al., 2011; Wannamethee et al., 2015; Roussel et al., 2016; Jensen et al., 2019).